Literature DB >> 194632

Possible mechanisms involved in the stereotyped behavior elicited by amphetamine.

P M Groves.   

Abstract

In a variety of animals, amphetamine administration produces an increase in locomotor behavior and an induction of repetitive, stereotyped behaviors. There is now considerable evidence to suggest that the induction of stereotyped behaviors is accomplished, in part, by alterations in catecholaminergic transmission in the central nervous system. By recording the spontaneous activity of neurons in the rat brain substantia nigra, reticular formation, basal ganglia, and elsewhere during systemic administration of amphetamine and related drugs, or during administration by means of microinfusions directly into these brain regions, relationships may be drawn between the biochemical and behavioral effects of these drugs and drug-induced changes in neuronal activity in the central nerovous system. Current evidence, for example, suggests that amphetamine produces an inhibition of neuronal activity in the neostriatum and pars compacta of the substantia nigra by means of dopamine released from dopaminergic terminals in the neostriatum and dopaminergic dendrites in the substantia nigra respectively. In addition, current evidence suggests the possibility of a GABA-mediated functional antagonism between excitatory cortical and/or thalamic input to the neostriatum and dopaminergic input from the substantia nigra which could be involved in the apparently mutually exclusive occurrence of amphetamine-induced locomotion and stereotyped behaviors that follow amphetamine administration. Such evidence may also have relevance to a variety of behavioral disorders involving the basal ganglia and catecholaminergic transmission in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194632

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  5 in total

1.  Experimental modeling of cellular mechanisms of some psychopathological syndromes.

Authors: 
Journal:  Neurosci Behav Physiol       Date:  1987 May-Jun

2.  Activation of striatal neurons by dexamphetamine is antagonized by degeneration of striatal dopaminergic terminals.

Authors:  M W Warenycia; G M McKenzie
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

3.  Response sensitization and depression following long-term amphetamine treatment in a self-stimulation paradigm.

Authors:  L Kokkinidis; R M Zacharko
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

4.  Dopaminergic mechanisms and cognitive deficit in schizophrenia. A neurobiological model.

Authors:  M H Joseph; C D Frith; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

Review 5.  Stimulant drug effects in developmental disorders and hyperactivity--toward a resolution of disparate findings.

Authors:  M G Aman
Journal:  J Autism Dev Disord       Date:  1982-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.